Using Supervised Injection Facilities to Reduce Harm and Improve Access to Care
Sharon Stancliff, MD, FAAFP, FASAM
Sharon Stancliff, MD, FAAFP, FASAM
Medical Director
Harm Reduction Coalition, New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2017. All rights reserved.
Sharon Stancliff is the Medical Director of the Harm Reduction Coalition where she provides training and capacity building services on issues related to drug user health in New York, nationally and internationally. Currently she focuses on overdose prevention and on expanding buprenorphine services. Dr. Stancliff graduated from the School of Medicine at University of California at Davis, did her Family Practice residency at the University of Arizona and completed the AIDS Institute-sponsored Nicolas Rango HIV Clinical Scholars Program. She is board certified in Family Medicine, and in Addiction Medicine.
At the completion of this educational session, learners will:
- Understand the evidence for the effectiveness of Supervised Injection Facilities (SIFs) in reducing overdose, HIV and HCV transmission, and other harms of injection drug use.
- Appreciate how existing SIFs fit into a continuum of care.
- Know several models of SIFs.
- Be aware of legal barriers to these facilities in the United States.
This CME activity was approved for
AMA PRA Category 1 Credit™ on February 07, 2017 and will terminate February 6, 2020.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Stancliff (Presenter) has no relevant financial relationships to disclose. Dr. Stancliff submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the
PRN Courses Page at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
